A detailed history of Cornerstone Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Advisory, LLC holds 6,643 shares of BMY stock, worth $383,699. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,643
Previous 8,024 17.21%
Holding current value
$383,699
Previous $333,000 3.0%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $54,770 - $71,466
-1,381 Reduced 17.21%
6,643 $343,000
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $135,521 - $178,417
-3,367 Reduced 29.56%
8,024 $333,000
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $30,035 - $34,054
626 Added 5.82%
11,391 $617,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $146,603 - $174,938
-3,024 Reduced 21.93%
10,765 $552,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $26,513 - $29,646
-458 Reduced 3.21%
13,789 $800,000
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $24,974 - $27,730
-392 Reduced 2.68%
14,247 $911,000
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $51,713 - $58,655
-787 Reduced 5.1%
14,639 $1.01 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $76,697 - $90,820
1,120 Added 7.83%
15,426 $1.11 Million
Q3 2022

Oct 26, 2022

BUY
$0.13 - $76.84 $37 - $22,129
288 Added 2.05%
14,306 $1.02 Million
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $451,042 - $496,755
-6,211 Reduced 30.7%
14,018 $1.08 Million
Q1 2022

May 20, 2022

BUY
$61.48 - $73.72 $272,848 - $327,169
4,438 Added 28.1%
20,229 $1.48 Million
Q4 2021

Feb 23, 2022

SELL
$53.63 - $62.52 $161,801 - $188,622
-3,017 Reduced 16.04%
15,791 $984,000
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $473 - $554
8 Added 0.04%
18,808 $1.11 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $256,431 - $279,253
4,142 Added 28.26%
18,800 $1.26 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $82,363 - $92,635
1,388 Added 10.46%
14,658 $926,000
Q4 2020

May 11, 2021

BUY
$57.74 - $65.43 $346 - $392
6 Added 0.05%
13,270 $824,000
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $225,297 - $249,659
3,923 Added 42.0%
13,264 $799,000
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $27,574 - $32,237
503 Added 5.69%
9,341 $549,000
Q1 2020

May 11, 2020

BUY
$46.4 - $67.43 $110,849 - $161,090
2,389 Added 37.04%
8,838 $493,000
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $21,012 - $27,409
-427 Reduced 6.21%
6,449 $414,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $7,869 - $9,330
-184 Reduced 2.61%
6,876 $349,000
Q1 2019

May 08, 2019

SELL
$45.12 - $53.8 $1,488 - $1,775
-33 Reduced 0.47%
7,060 $337,000
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $55,440 - $71,892
1,137 Added 19.09%
7,093 $369,000
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $3,697 - $4,170
67 Added 1.14%
5,956 $370,000
Q2 2018

Aug 09, 2018

SELL
$50.53 - $62.98 $9,297 - $11,588
-184 Reduced 3.03%
5,889 $326,000
Q1 2018

May 10, 2018

BUY
$59.92 - $68.98 $1,977 - $2,276
33 Added 0.55%
6,073 $384,000
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $7,012 - $7,645
117 Added 1.98%
6,040 $370,000
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $8,284 - $9,561
-150 Reduced 2.47%
5,923 $378,000
Q2 2017

Aug 08, 2017

BUY
N/A
6,073
6,073 $338,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cornerstone Advisory, LLC Portfolio

Follow Cornerstone Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisory, LLC with notifications on news.